Effects of angiotensin, norepinephrine and renal artery constriction on erythropoietin production.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001681:Biological Assay; D001783:Blood Flow Velocity; D001795:Blood Pressure Determination; D004285:Dogs; D004912:Erythrocytes / Q000378:metabolism; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000096:biosynthesis* / Q000097:blood; D005215:Fasting; D005260:Female; D006400:Hematocrit; D007263:Infusions, Parenteral; D007501:Iron / Q000378:metabolism; D007503:Iron Isotopes; D008297:Male; D051379:Mice; D011086:Polycythemia / Q000209:etiology; D051381:Rats; D012078:Renal Artery Obstruction / Q000378:metabolism*
D007503:Iron Isotopes; D004921:Erythropoietin; D000804:Angiotensin II; D007501:Iron